Supreme Pharmaceuticals Inc:Says John Fowler was elected to the board of directors and appointed as President of company.
AstraZeneca Plc:Says that the US Food and Drug Administration has approved LYNPARZA(olaparib) capsules (400mg twice daily) as first monotherapy.Approves for patients with deleterious or suspected deleterious germline BRCA-mutated (g BRCAm) advanced ovarian cancer, who have been treated with three or...
Roche Holding AG:Says the acquisition of Bina Technologies, Inc., a privately held company based in Redwood City, California, USA.Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data.Bina's proprietary on-market Genomic Management...
Teva Pharmaceutical Industries Ltd announces FDA approval of QNASL Nasal Aerosol for treatment of children with seasonal and Perennial Allergic Rhinitis
Teva Pharmaceutical Industries Ltd:Says that U.S. Food and Drug Administration (FDA) approved QNASL 40 mcg for treatment of nasal symptoms associated with allergic rhinitis (AR) in children 4-11 years of age.QNASL 40 mcg is lower dose formulation of QNASL Nasal Aerosol, waterless (non-aqueous)...
Restructuring & Reorganization
No related earnings announcements are currently scheduled within the next 7 days.